A simple protocol for using a LDH-based cytotoxicity assay to assess the effects of death and growth inhibition at the same time.

by Shilo M Smith, Michael B Wunder, David A Norris, Yiqun G Shellman
Published 2011-01-01

CPP‐E1A fusion peptides inhibit CtBP‐mediated transcriptional repression

by Melanie A. Blevins, Caiguo Zhang, Lingdi Zhang, Hong Li, Xueni Li, David A. Norris, Mingxia Huang, Rui Zhao
Published 2018-08-01

The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53.

by Steven N Reuland, Nathaniel B Goldstein, Katie A Partyka, David A Cooper, Mayumi Fujita, David A Norris, Yiqun G Shellman
Published 2011-01-01

ABT-737 synergizes with Bortezomib to kill melanoma cells

by Steven N. Reuland, Nathaniel B. Goldstein, Katie A. Partyka, Shilo Smith, Yuchun Luo, Mayumi Fujita, Rene Gonzalez, Karl Lewis, David A. Norris, Yiqun G. Shellman
Published 2012-02-01

Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma.

by Yuchun Luo, Steven Robinson, Junichi Fujita, Lisa Siconolfi, Jay Magidson, Carl K Edwards, Karl Wassmann, Kathleen Storm, David A Norris, Danute Bankaitis-Davis, William A Robinson, Mayumi Fujita
Published 2011-01-01

Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy alone...

by Carl K Edwards, Carl K Edwards, Julie Schwartz Green, Hans-Dieter eVolk, Michael eSchiff, Brian eKotzin, Hiroaki eMitsuya, Tatsuya eKawaguchi, Ken-Mei eSakata, John eCheronis, David eTrollinger, Danute eBankaitis-Davis, Charles A Dinarello, David A Norris, David A Norris, Michael P Bevilacqua, Mayumi eFujita, Mayumi eFujita, Gerd-Rudiger eBermester
Published 2012-12-01

A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine

by Chiara R. Dart, Nabanita Mukherjee, Carol M. Amato, Anabel Goulding, Morgan MacBeth, Robert Van Gulick, Kasey L. Couts, James R. Lambert, David A. Norris, William A. Robinson, Yiqun G. Shellman
Published 2021-07-01

Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma

by Nabanita Mukherjee, Carol M. Amato, Jenette Skees, Kaleb J. Todd, Karoline A. Lambert, William A. Robinson, Robert Van Gulick, Ryan M. Weight, Chiara R. Dart, Richard P. Tobin, Martin D. McCarter, Mayumi Fujita, David A. Norris, Yiqun G. Shellman
Published 2020-08-01